openMedicine project word cloud
Explore the words cloud of the openMedicine project. It provides you a very rough idea of what is the project "openMedicine" about.
Project "openMedicine" data sheet
The following table provides information about the project.
| Coordinator |
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH
Organization address contact info |
| Coordinator Country | Germany [DE] |
| Project website | http://www.open-medicine.eu |
| Total cost | 997˙938 € |
| EC max contribution | 997˙938 € (100%) |
| Programme |
1. H2020-EU.3.1.5. (Methods and data) |
| Code Call | H2020-PHC-2014-single-stage |
| Funding Scheme | CSA |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-01-01 to 2016-12-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH | DE (BONN) | coordinator | 191˙875.00 |
| 2 | CUSTODIX NV | BE (SINT-MARTENS-LATEM) | participant | 299˙625.00 |
| 3 | HEALTH PRODUCTS REGULATORY AUTHORITY | IE (DUBLIN) | participant | 110˙625.00 |
| 4 | HL7 INTERNATIONAL FONDATION | BE (BRUSSELS) | participant | 90˙313.00 |
| 5 | SIEC BADAWCZA LUKASIEWICZ INSTYTUTLOGISTYKI I MAGAZYNOWANIA | PL (POZNAN) | participant | 87˙625.00 |
| 6 | REGIONE LOMBARDIA | IT (MILANO) | participant | 80˙625.00 |
| 7 | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS | ES (MADRID) | participant | 74˙375.00 |
| 8 | STICHTING KONINKLIJK NEDERLANDS NORMALISATIE INSTITUUT | NL (DELFT) | participant | 62˙875.00 |
Map
Project objective
The CSA will enhance the safety of cross-border healthcare through interoperable ePrescriptions. epSOS solved the message transfer problem, but encountered 2 serious “delivery” problems: the univocal identification of medicinal products (MPs) dispensed abroad, and substitution challenges. Global SDOs (WHO, HL7, IHTSDO, ISO/CEN, GS1), EU regulatory agencies (EMA), MS Competent Authorities, major stakeholders (industry, health professionals, patients) harmonise their related efforts to deliver • common data models - expanding upon epSOS and existing standards (ISO/IDMP) - for prescribed MPs • a common meta-vocabulary for unambiguous definition, description, and identification of MPs • rules to harmonise practices of therapeutic and economic substitution • a roadmap for post-project actions and implementations • policy recommendations for the EU-USA road mapping process (MoU) Work will link to related research & innovation activities of SDOs, epSOS, policy and regulatory processes (eHealth Network), the three other PHC34 projects. WP1 develops a concise conceptual framework, including use case scenarios where the identification of a MP is an issue, including pharmacological and pharmacokinetic attributes, clinical indications and risks. WPs 2 address the identification and description of the pharmaceutical products, considering implementability as essential. WP3 investigates the situation in MSs with respect to substitution, and explores options for substitution. Each track develops a set of concrete solutions and road map recommendations, validated by experts in F2F meetings and workshops in WP4. Fostering exploitation by MS regulatory agencies and communication of results is the duty of WP5. The project involves national competent authorities, SDOs and stakeholders not part of the core team at an early stage to assure the practicability, acceptance and trust in the solutions developed. The CSA lasts 2 years involving 8 beneficiaries and about 25 expert organisations.
Deliverables
| D6.1 1st annual report on the activities of the Expert Council | Documents, reports | 2019-07-23 09:11:13 |
| D2.1 Report on standards based identification and description enabling dispensing equivalent medicinal products | Documents, reports | 2019-07-23 09:11:14 |
| D1.2 Complementary uses cases | Documents, reports | 2019-07-23 09:11:14 |
| D1.1 epSOS identification/description problems | Documents, reports | 2019-07-23 09:11:14 |
| D2.3 openMedicine final identifying and descriptive attributes | Documents, reports | 2019-07-23 09:11:14 |
| D8.2 openMedicine portal online | Websites, patent fillings, videos etc. | 2019-07-23 09:11:14 |
| D5.2 openMedicine substitution: options and roadmap | Documents, reports | 2019-07-23 09:11:13 |
| D5.1 Meeting the substitution challenge: Member State regulations and core cross-border issues | Documents, reports | 2019-07-23 09:11:13 |
| D7.1 Communication Plan | Documents, reports | 2019-07-23 09:11:13 |
| D6.2 Report on validation activities | Documents, reports | 2019-07-23 09:11:13 |
| D1.3 Initial openMedicine infostructure | Documents, reports | 2019-07-23 09:11:14 |
| D7.2 1st Communication and Liaison Report | Documents, reports | 2019-07-23 09:11:14 |
| D7.3 2nd Communication and Liaison Report | Documents, reports | 2019-07-23 09:11:14 |
| D6.4 2nd annual report on the activities of the Expert Council | Documents, reports | 2019-07-23 09:11:14 |
| D6.3 openMedicine Recommendations and Roadmap for Implementation | Documents, reports | 2019-07-23 09:11:13 |
| D2.2 Comprehensive set of openMedicine identifying and descriptive attributes of medicinal products and the available standards | Documents, reports | 2019-07-23 09:11:14 |
Take a look to the deliverables list in detail: detailed list of openMedicine deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OPENMEDICINE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OPENMEDICINE" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.1.5.)
EUCANCan (2019)
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.
Read MoreiReceptor Plus (2019)
ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY
Read MoreeuCanSHare (2018)
An EU-Canada joint infrastructure for next-generation multi-Study Heart research
Read More